PositoAI/ US/ Ovid Therapeutics Inc.

Ovid Therapeutics Inc.

NasdaqCM: OVID · Healthcare

Positivity Index

#4,564 / 6,774

Global

#2,315 / 4,000

United States

Positivity Score

19,279

Rank→

Overview Go Deep Penta Pattern Funda News For this company Histo

PosiRed: no active red flags

Ovid Therapeutics Inc. — Overview & Financial Snapshot

Ovid Therapeutics Inc. (NasdaqCM: OVID) is a Healthcare company, ranked #4,564 of 6,774 companies globally and #2,315 of 4,000 in United States on PositoAI, with a Positivity Score of 19,279. Its market capitalisation is ₹4,368.93 Cr ($462.86M), P/E ratio is -10.8 and P/B ratio is 2.21. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#3 Dogwood Therapeutics, Inc. 27,827 #8 Impact BioMedical Inc. 26,149 #13 Onconetix, Inc. 25,902 #15 Revelation Biosciences, Inc. 25,780 #18 Vyome Holdings, Inc. 25,696

— Nothing to show —

OpenAI is reading recent news...

Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.

P/B Ratio 2.21

P/E Ratio -10.8

D/E Ratio 0.06

ROE -25.96%

Owes vs Owns ? 0.10× Low $0.10 owed for every $1 it owns · balance sheet Jun 2026

Dividend Yield 0.00%

Trailing EPS ₹-20.77$-0.22

Forward EPS ₹-34.61$-0.37

Beta 0.23

Market Cap ₹4,368.93 Cr$462.86M

What these numbers mean →

What does Ovid Therapeutics Inc. do?

What is Ovid Therapeutics Inc.'s P/E and P/B ratio?

Ovid Therapeutics Inc. has a P/E ratio of -10.8 and a P/B ratio of 2.21.

What is Ovid Therapeutics Inc.'s debt-to-equity ratio?

Ovid Therapeutics Inc. has a debt-to-equity ratio of 0.06.

How much does Ovid Therapeutics Inc. owe compared with what it owns?

Ovid Therapeutics Inc. owes $0.10 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Ovid Therapeutics Inc.'s Positivity rank?

Ovid Therapeutics Inc. is ranked #4,564 of 6,774 companies globally and #2,315 of 4,000 in United States on PositoAI, with a Positivity Score of 19,279.

Does Ovid Therapeutics Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Ovid Therapeutics Inc..

Where can I read the latest news about Ovid Therapeutics Inc.?

Recent headlines about Ovid Therapeutics Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Ovid Therapeutics Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Ovid Therapeutics Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.